...
首页> 外文期刊>Life sciences >Curative effects of hydrogen sulfide against acetaminophen-induced hepatotoxicity in mice.
【24h】

Curative effects of hydrogen sulfide against acetaminophen-induced hepatotoxicity in mice.

机译:硫化氢对乙酰氨基酚引起的小鼠肝毒性的疗效。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AIMS: Hydrogen sulfide (H(2)S), an endogenous gaseous mediator, plays an important role in regulation of many physiological and pathological processes. On the other hand, acetaminophen overdose is a major cause of drug-induced liver failure. The aim of this study therefore is to evaluate the possible curative effects of H(2)S against acetaminophen-induced hepatotoxicity. MAIN METHODS: Male Swiss mice were treated with sodium hydrogen sulfide, a H(2)S donor, 30 min after acetaminophen administration. N-acetylcysteine, a therapeutic antidote, was used as a reference drug. KEY FINDINGS: H(2)S treatment resulted in hepatocurative effects as evident by a significant decrease in serum alanine aminotransferase and hepatic malondialdehyde and nitric oxide levels, with a concurrent increase in hepatic glutathione content compared to acetaminophen-treated group. H(2)S did not alter catalase activity. Additionally, immunohistochemical analysis demonstrated that H(2)S treatment markedly reduced tumor necrosis factor-alpha expression, while expression of cyclooxygenase-2 was markedly enhanced with nuclear localization into hepatocytes. The curative effects of H(2)S were confirmed by liver histopathological examination and were maintained in the presence of glibenclamide, an antagonist of ATP-sensitive potassium (K(ATP)) channels. SIGNIFICANCE: H(2)S treatment markedly alleviates acetaminophen hepatotoxicity in mice possibly, in part, through anti-oxidative and anti-inflammatory effects but not likely to be coupled with activation of K(ATP) channels. The hepatocurative effects of H(2)S are comparable to N-acetylcysteine. Hence, H(2)S has a potential therapeutic value for treatment of acetaminophen hepatotoxicity.
机译:目的:硫化氢(H(2)S),一种内源性气态介质,在许多生理和病理过程的调节中起着重要作用。另一方面,对乙酰氨基酚过量是引起药物性肝衰竭的主要原因。因此,本研究的目的是评估H(2)S对乙酰氨基酚诱导的肝毒性的可能疗效。主要方法:对乙酰氨基酚给药后30分钟,用H(2)S供体硫化氢钠处理雄性瑞士小鼠。 N-乙酰半胱氨酸,一种治疗性解毒剂,被用作参考药物。关键发现:H(2)S治疗可引起肝硬化作用,这与对乙酰氨基酚治疗组相比,血清丙氨酸氨基转移酶和肝丙二醛和一氧化氮水平显着降低,同时肝谷胱甘肽含量增加。 H(2)S不会改变过氧化氢酶活性。此外,免疫组织化学分析表明,H(2)S治疗显着降低了肿瘤坏死因子-α的表达,而环氧合酶2的表达则随着核定位进入肝细胞而显着增强。 H(2)S的疗效已通过肝脏组织病理学检查证实,并在格列本脲存在下得以维持,后者是ATP敏感性钾(K(ATP))通道的拮抗剂。意义:H(2)S处理可部分减轻小鼠对乙酰氨基酚的肝毒性,这可能部分是通过抗氧化和抗炎作用,但不太可能与激活K(ATP)通道相结合。 H(2)S的肝硬化作用与N-乙酰半胱氨酸相当。因此,H(2)S具有对乙酰氨基酚肝毒性的潜在治疗价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号